Becker's Healthcare May 16, 2023
Noah Schwartz

Google Cloud launched the Target and Lead Identification Suite and the Multiomics Suite, two artificial intelligence-powered tools designed to accelerate drug discovery.

The Target and Lead Identification Suite works to help researchers predict protein structure and identify the amino acid function. The Multiomics Suite aims to help companies developing precision medicine tools interpret genomic data, according to a May 16 Google Cloud news release.

Pfizer and Cerevel are using the Target and Lead...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Pharma, Pharma / Biotech, Precision Medicine, Technology
Related Articles:
What Musk is telling Trump on AI regulation is anyone's guess
How AI is Transforming the Acute Patient Journey
Microsoft brings transactional databases to Fabric to boost AI agents
How each generation sees AI: a reflection on adaptation
An AI pressure test

Share This Article